Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.32
0.143.35%
Last update: Dec 15, 8:54 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cingulate (CING) stock?
You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.
Who are Cingulate (CING) competitors?
Other companies in Cingulate’s space includes: Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Iterum Therapeutics PLC (NASDAQ:ITRM), SCYNEXIS Inc (NASDAQ:SCYX), Telomir Pharmaceuticals Inc (NASDAQ:TELO) and Tvardi Therapeutics Inc (NASDAQ:TVRD).
What is the forecast, or price target, for Cingulate (CING) stock?
Cingulate has a consensus price target of $26.50.
What is the current price for Cingulate (CING)?
The stock price for Cingulate (NASDAQ: CING) is $4.32 last updated December 15, 2025 at 8:54 AM EST.
Does Cingulate (CING) pay a dividend?
There are no upcoming dividends for Cingulate.
When is Cingulate (NASDAQ:CING) reporting earnings?
Cingulate does not have any upcoming earnings scheduled.
Is Cingulate (CING) going to split?
There is no upcoming split for Cingulate.
What sector and industry does Cingulate (CING) operate in?
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
